Clinical Trial Update: PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating cytoreduction surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for gastric cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Banner Health | Conditions: Gastric Adenocarcinoma | Phase 2 | Status: RECRUITING